These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8519034)

  • 21. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Benfield P; Heel RC; Lewis SP
    Drugs; 1986 Dec; 32(6):481-508. PubMed ID: 2878798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost of treatment dropout in depression. A cost-benefit analysis of fluoxetine vs. tricyclics.
    Le Pen C; Levy E; Ravily V; Beuzen JN; Meurgey F
    J Affect Disord; 1994 May; 31(1):1-18. PubMed ID: 8046156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication.
    Wong DT; Bymaster FP; Engleman EA
    Life Sci; 1995; 57(5):411-41. PubMed ID: 7623609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of depression in comorbid medical illness.
    Goodnick PJ; Hernandez M
    Expert Opin Pharmacother; 2000 Dec; 1(7):1367-84. PubMed ID: 11249471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SSRI efficacy-finding the right dose.
    Caley CF; Kando JC
    J Psychiatr Pract; 2002 Jan; 8(1):33-40. PubMed ID: 15985852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical studies of fluoxetine in depression.
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():1-119. PubMed ID: 2644334
    [No Abstract]   [Full Text] [Related]  

  • 27. Benign course in a child with a massive fluoxetine overdose.
    Feierabend RH
    J Fam Pract; 1995 Sep; 41(3):289-91. PubMed ID: 7650509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine and dreaming.
    Markowitz JC
    J Clin Psychiatry; 1991 Oct; 52(10):432. PubMed ID: 1938980
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluoxetine. A new antidepressant.
    Poe TE
    N C Med J; 1988 Jul; 49(7):391-2. PubMed ID: 3063975
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonergic activity and hostility.
    Everett HC
    J Clin Psychiatry; 1990 Oct; 51(10):438-9. PubMed ID: 2211544
    [No Abstract]   [Full Text] [Related]  

  • 31. Are SSRI antidepressants clinically homogeneous?
    Carroll BJ
    Lancet; 1994 Aug; 344(8921):550. PubMed ID: 7914647
    [No Abstract]   [Full Text] [Related]  

  • 32. Your patient and Prozac.
    Matney J
    RDH; 1991 Mar; 11(3):31-2. PubMed ID: 1887080
    [No Abstract]   [Full Text] [Related]  

  • 33. Thinking about Prozac.
    Barondes SH
    Science; 1994 Feb; 263(5150):1102-3. PubMed ID: 8108727
    [No Abstract]   [Full Text] [Related]  

  • 34. Unlocking Therapeutic Synergy: Tailoring Drugs for Comorbidities such as Depression and Diabetes through Identical Molecular Targets in Different Cell Types.
    Coppola T; Daziano G; Legroux I; Béraud-Dufour S; Blondeau N; Lebrun P
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Black Book of Psychotropic Dosing and Monitoring.
    Schatzberg AF; Charles D
    Psychopharmacol Bull; 2018 Jan; 48(1):64-153. PubMed ID: 29382960
    [No Abstract]   [Full Text] [Related]  

  • 36. ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis.
    Lin CH; Huang CJ; Chen CC
    Int J Neuropsychopharmacol; 2018 Jan; 21(1):63-72. PubMed ID: 29228200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological and behavioural antidepressant treatment responses with the selective serotonin reuptake inhibitor fluoxetine can be determined by the environment.
    Licinio AW; Wong ML; Licinio J
    Mol Psychiatry; 2017 Apr; 22(4):484. PubMed ID: 28331212
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute fluoxetine exposure alters crab anxiety-like behaviour, but not aggressiveness.
    Hamilton TJ; Kwan GT; Gallup J; Tresguerres M
    Sci Rep; 2016 Jan; 6():19850. PubMed ID: 26806870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central nervous system drug evaluation using positron emission tomography.
    Sekine M; Maeda J; Shimada H; Nogami T; Arakawa R; Takano H; Higuchi M; Ito H; Okubo Y; Suhara T
    Clin Psychopharmacol Neurosci; 2011 Apr; 9(1):9-16. PubMed ID: 23431048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer patients' perspectives on discontinuing depression treatment: the "drop out" phenomenon.
    Wells AA; Palinkas LA; Qiu X; Ell K
    Patient Prefer Adherence; 2011; 5():465-70. PubMed ID: 22003283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.